Marijic, P., Schwarzkopf, L., Schwettmann, L., Ruhnke, T., Trudzinski, F., & Kreuter, M. (2021). Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: A retrospective cohort study. Respiratory research, 22, . https://doi.org/10.1186/s12931-021-01857-y
Chicago-Zitierstil (17. Ausg.)Marijic, Pavo, Larissa Schwarzkopf, Lars Schwettmann, Thomas Ruhnke, Franziska Trudzinski, und Michael Kreuter. "Pirfenidone Vs. Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: A Retrospective Cohort Study." Respiratory Research 22 (2021). https://doi.org/10.1186/s12931-021-01857-y.
MLA-Zitierstil (9. Ausg.)Marijic, Pavo, et al. "Pirfenidone Vs. Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: A Retrospective Cohort Study." Respiratory Research, vol. 22, 2021, https://doi.org/10.1186/s12931-021-01857-y.